Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Product Availability Update

Promega Manufacturing and Delivery Systems continue to be fully operational during the COVID-19 outbreak. Our teams are in regular contact with suppliers and distributors worldwide and are taking all steps necessary to address both demands for diagnostic tools and reliable delivery of all products as quickly as possible. Learn more

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

NanoBRET: A Quantitative Technique to Measure Kinase Target Engagement in Live Cells

Summary

Intracellular target selectivity is a key aspect of pharmacological mechanism. Although a number of acellular techniques have been developed to quantitatively measure kinase binding or enzymatic inhibition, currently no biophysical approaches exist that offer quantitative analysis of target occupancy or drug affinity in live cells. Here we report the application of an energy transfer technique (NanoBRET) that enables the first quantitative approach to broadly profile kinase occupancy under thermodynamic equilibrium with the test compound inside live cells. This approach enabled a mechanistic interrogation of the potency offsets observed between cellular and acellular analysis of kinase engagement, and uncovered improved intracellular selectivity profiles for certain clinically-relevant multi-kinase inhibitors. The energy transfer technique can also be performed in real time, enabling assessments of compound residence time. Applications of NanoBRET for the measurements of target engagement and residence time for ATP-competitive and non-competitive inhibitors will be presented.


Speaker

matt-robers-125x125

Matthew Robers
Sr Research Scientist & Group Leader
Promega Corporation

Matthew Robers is a Senior Research Scientist and Group Leader at Promega Corporation. Matthew has authored 30 peer-reviewed publications and published patents on the application of novel assay chemistries to measure intracellular protein dynamics. Matthew's team currently focuses on the development of new technologies to assess target engagement, emphasizing techniques enabling quantitative analysis of compound affinity and residence time at selected targets within intact cells.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up